OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
6
Results
Show all
Save search
Copy query
Show results for
Unknown
(6)
Publication Date
Release Date
2018
(1)
2016
(1)
2015
(1)
2013
(1)
2005
(1)
2004
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: ALTERNATIVE.
Not available
S-EPMC7444639
|
biostudies-literature
Cite
Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer.
Not available
S-EPMC7787348
|
biostudies-literature
Cite
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
Not available
S-EPMC4631139
|
biostudies-literature
Cite
A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial.
Not available
S-EPMC4804122
|
biostudies-literature
Cite
Somatic mutations of KIT in familial testicular germ cell tumours.
Not available
S-EPMC2410291
|
biostudies-literature
Cite
The Y deletion gr/gr and susceptibility to testicular germ cell tumor.
Not available
S-EPMC1285161
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets